Close Menu

cell array

The firm plans to integrate its technology with a compatible microfluidic sample prep method developed by researchers at Columbia University.

Researchers screened cancer cell lines to detect mutations and drug combinations that might sensitize tumors to drugs that impair anti-apoptosis proteins.

Researchers at the VTT Technical Research Centre in Finland have developed a miniaturized cell microarray platform that they claim can be used in large-scale gene knockdown analyses.

CEO Barry Bochner said that Biolog will use the funds to continue adapting its Phenotype Microarray platform to study Mycobacterium tuberculosis and other fastidious pathogens, expand its Microbial Identification System to cover more fastidious species, and work with researchers at Texas A&M University to study gene function in Mycobacterium.

NPR reports the US Food and Drug Administration has approved a treatment for a genetic disorder that causes rapid aging.

Late-stage testing indicates the AstraZeneca and Oxford University SARS-CoV-2 vaccine can have up to 90 percent efficacy, the Associated Press reports.

ScienceInsider reports Nature Communications is reviewing a paper on mentorship following social media criticism arguing it is sexist.

In PLOS this week: method to account for sequencing errors in phylogenies, study of influenza A in Switzerland, and more.